Home | Welcome to Contract Pharma   
Last Updated Tuesday, November 25 2014
Print

Search Results for 'Financial Report: AMRI 3Q'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published October 28, 2014
Revenue up 4% in the quarter Read More »
Published October 25, 2012
Seroquel IR losses account for big drop in revenues Read More »
Published November 8, 2011
Achieves 17% growth in large-scale manufacturing, exits internal pharma R&D Read More »
Published November 9, 2010
Total contract revenue for the quarter was $42.9 million (+8%). Read More »
Published November 7, 2008
AMRI 3Q Revenues: $61.4 million (+29%) 3Q Earnings: $7.0 million (+250%) YTD Revenues: $172.9 million (+19%) YTD Earnings: $17.4 million (+78%) Comments: Total contract revenue for the quarter was $54.1 million (+30%). Discovery Servi… Read More »
Published November 9, 2006
AMRI 3Q Revenues: $44.2 million (flat) 3Q Earnings: $1.4 million (-68%) YTD Revenues: $133.2 million (-8%) YTD Earnings: $2.9 million (-83%) Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract reve… Read More »
AMRI
By Gina Rothe, Manager, Marketing Communications
AMRI is a global contract research and manufacturing organization offering integrated drug discovery, development, and manufacturing services. AMRI's experience, a track record of success and locations in North America, Europe and Asia provide ou… Read More »
Published October 16, 2008
Abbott 3Q Revenues: $7.5 billion (+18%) 3Q Earnings: $1.1 billion (+51%) YTD Revenues: $22.0 billion (+15%) YTD Earnings: $3.3 billion (+39%) Comments: Worldwide pharmaceutical sales were $4.1 billion in the quarter (+17%), driven by g… Read More »
Published October 7, 2014
Invests in humidity controlled blister packaging Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On